MIRA INFORM REPORT
|
Report Date : |
07.08.2012 |
IDENTIFICATION DETAILS
|
Name : |
LABORATORIOS MAR S.A. |
|
|
|
|
Registered Office : |
Avda. Gaona 3875, Buenos Aires City |
|
|
|
|
Country : |
Argentina |
|
|
|
|
Financials (as on) : |
31.03.2011 |
|
|
|
|
Date of Incorporation : |
03.03.1999 |
|
|
|
|
Legal Form : |
Public Limited Company |
|
|
|
|
Line of Business : |
Processing and
Marketing of Medical Specialties for Human Use. |
|
|
|
|
No. of Employees
: |
33 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 32000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Argentina |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
LABORATORIOS MAR
S.A.
C.U.I.T. 30-70207068-2
BEGINNER OF ACTIVITIES. INCORPORATED IN
1999. BALANCE SHEET AS OF 31/03/2011: RESULT POSITIVE OF REASONABLE IMPORTANCE
AND ADEQUATE STRUCTURE ECONOMIC/FINANCIAL. FIT FOR OPERATIONS OF MEDIUM
IMPORTANCE AND ADDITIONAL GUARANTEES.
> PROCESSING AND MARKETING OF MEDICAL
SPECIALTIES FOR HUMAN USE.
LEGAL FORM:
PUBLIC LIMITED COMPANY
CREATED: 03/03/1999
REGISTERED R.P.C.: 1999
DURATION: 99
YEARS
END OF FISCAL YEAR: 31 MARCH
Accountant: Dario De Valle
Legal and operative address: Avda.
Gaona 3875, Buenos Aires City, Argentina.
Phone: (54-11)
4582-5090 y 4582.2929
E.Mail: administracion@laboratoriosmar.com.ar
PRESIDENT:
DIEGO EMILIANO MARTINEZ
V.PRESIDENT: RODRIGO OSVALDO MARTINEZ URIA
DIRECTOR: SILVINA GABRIELA MARTINEZ
URIA
Use of signature: President and V.President.
This Board was appointed Special Meeting of July 29, 2011 Registration 1147
where he also will increase its share capital stated in the corresponding
items.
It was published in the Official Gazette of Argentina No. 32281 of November 21,
2011.
Ordinary
shares:
----------------
Subscribed and integrated $ 1.068.666.-
MARTINEZ
URIA RODRIGO OSVALDO:
-------------------------------
argentino,
married, born 23/1/1975, D.N.I. No. 24.424.476
MARTINEZ URIA SILVINA GABRIELA:
------------------------------
argentina, single, born 27/5/1977, D.N.I. 26.001.156
As appears from the findings that have been
made, the activities in question were initiated and implemented by this
society, which is governed by legal clauses above.
It is known that members of this society develop other commercial activities.
This is an Argentine laboratory from its genesis, is composed of human beings
that share principles that require them to assume a social responsibility.
They have a social function to be met by medical laboratories.
Your organization deal with the conviction of knowing that every day, get the
best drugs in the hands of health professionals.
Balance sheet as 31 March 2011, expressed in
pesos argentinos.
Exchange: 1
DOLAR = $ 4,59
ASSETS CURRENT $ 5.200.580
ASSETS NON-CURRENT $
1.520.687
LIABILITIES CURRENT
$ 1.040.202
LIABILITIES NON-CURRENT $
2.653.343
NET WORTH $ 3.027.632
From the above figures it was possible to obtain the following indices:
WORKING CAPITAL
$ 4.160.288
CASH FLOW 4,99
CURRENT DEBT 0,34
TOTAL DEBT 1,22
RESPONSIBILITY EQUITY 0,81
TOTAL SOLVENCY 1,81
ECONOMIC COMMENTARY:
--------------------
The above figures show a good position economic / financial, such as
indexes to index cash and debt, having obtained his efforts a final profit of
18.5% on sales that is considered satisfactory.
Rotation of the company to date shows no adverse alternative and assigned to it
stable outlook.
REAL
ESTATE:
------------
-
Avda. Gaona 3875, Buenos Aires City, Argentina.
Surface covered of
VEHICLES:
---------
15 vehicles, are not obtained details.
DOBFAR SPA Italy
GRAFICA TGA S.A. Argentina
Payments: 90 days.
Crédits: u$s 35 and 50.000
Concept: Normal
Holder society is dedicated to the
preparation and marketing of medical specialties for human use. -
Centralizes their actions in reporting the address where he has made reasonable
operational structure.
FOREIGN TRADE:
--------------
From India, Swizerland, Italy, Free zone of
No export.
SOME OF YOUR PRODUCTS FOR ADULT AND
PEDIATRIC:
----------------------------------------------
> AMOXI 500
> AMOXI DUO MAR
> CEFAMAR
> DICLOMAR
> METAMAR
> METAMAR RETARD, and others.
Work with the following companies:
----------------------------------
IOMA - IAPOS - IOSCOR - INSSSEP - OSEP - PAMI - OSPRERA
MAIN SUPPLIERS:
---------------
DOBFAR SPA Italy
HETERO DRUGS LTD. India
GRAFICA TGA S.A. Argentina
LABORATORIOS FRASCA S.A. Argentina
* 33 EMPLOYEES.
BANCO CREDICOOP
Suc. Villa Sahores
BANCO CIUDAD DE BUENOS AIRES
Suc. Villa del Parque
INSURANCE:
----------
NACION SEGUROS S.A.
CREDIT RISK MAYO 2012
---------------------
BANCO CIUDAD $
489.100
BANCO CREDICOOP 69.200
BANCO SUPERVIELLE 8.500
SITUATION 1: NORMAL
To date no that would prejudice the
commercial concept of our informed and determined through investigations
carried out, maintaining a proper attention of the general commitments assumed.
* NOT OBJECTIONS.
It concludes that the company that owns may
be related to credit operations, in moderate amounts and with the conditions of
practice.
In larger amounts, you should required appropriate guarantees.
* FIT FOR CREDITS.
JMC
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.47 |
|
|
1 |
Rs.86.60 |
|
Euro |
1 |
Rs.68.66 |
INFORMATION DETAILS
|
Report Prepared
by : |
SDA |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.